SCHEMBL4854850

SCHEMBL4854850

CCCC(Br)CC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747628 0.84 LCK (0.50)
SCHEMBL6450865 0.82 TDP1 (0.40)
SCHEMBL1780149 0.80
SCHEMBL3825493 0.80
SCHEMBL8019674 0.79
SCHEMBL2002867 0.78
SCHEMBL29244176 0.78 TDP1 (0.41)
SCHEMBL9869453 0.78
SCHEMBL28713719 0.75 ALDH1A1 (0.37)
SCHEMBL5197011 0.75 CHRM1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232468-A A kind of camphorsulfonic acid thiosemicarbazones thiazole compound, preparation method and its application 南京林业大学 2019-01-18 CN claimed
CN-109232468-A A kind of camphorsulfonic acid thiosemicarbazones thiazole compound, preparation method and its application 南京林业大学 2019-01-18 CN disclosed
CN-102341379-B Benzothiazine derivative, its preparation method and the application as medicine thereof PIERRE FABRE MEDICAMENT (FR) 2015-08-26 CN disclosed
CN-102985411-A Imaging agents for detecting neurological disorders SIEMENS MEDICAL SOLUTIONS 2013-03-20 CN disclosed
CN-102341379-A Derivatives of benzothiazines, preparation thereof and application thereof as drugs PF MEDICAMENT 2012-02-01 CN disclosed
US-7405221-B2 Substituted pyrimidines MERCK & CO., INC. (US) 2008-07-29 US disclosed
US-20050245554-A1 Substituted pyrimidines MERCK SHARP & DOHME CORP. 2005-11-03 US disclosed
CN-1639146-A Fused tricyclic heterocycles useful for the treatment of hyperproliferative diseases BAYER PHARMACEUTICALS CORP (US) 2005-07-13 CN disclosed
EP-1546115-A2 SUBSTITUTED PYRIMIDINES Merck & Co., Inc. (US) 2005-06-29 EP disclosed
WO-2004029204-A2 SUBSTITUTED PYRIMIDINES MERCK & CO., INC. (US) 2004-04-08 WO disclosed
EP-0877024-B1 SUBSTITUTED 6-H-1,3,4-THIADIAZINE-2-AMINES, THE USE THEREOF AS AN AESTHETISING, CARDIOVASCULAR AND HYPOMETABOLIC AGENTS, AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM N T PREDPR LIGAND OBSCHESTVO S (RU) 2002-02-20 EP disclosed
EP-0877024-A1 SUBSTITUTED 6-H-1,3,4-THIADIAZINE-2-AMINES, THE USE THEREOF AS AN AESTHETISING, CARDIOVASCULAR AND HYPOMETABOLIC AGENTS, AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM THE PROCTER & GAMBLE COMPANY (US) 1998-11-11 EP disclosed
EP-0519449-A1 2-Amino-4-aryl thiazoles with antiasthmatic and antiinflammatory activities on the respiratory tract BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1992-12-23 EP disclosed